Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy
Open Access
- 29 October 2007
- journal article
- viral hepatitis
- Published by Wolters Kluwer Health in Hepatology
- Vol. 46 (5) , 1365-1374
- https://doi.org/10.1002/hep.21829
Abstract
Hepatitis C virus (HCV) has been known to replicate with extremely varying efficiencies in different host cells, even within different populations of a single human hepatoma cell line, termed Huh-7. Several reports have implicated the retinoic-acid inducible gene I (RIG-I)/ interferon regulatory factor 3 (IRF-3) pathway of the innate antiviral response with differences in host cell permissiveness to HCV. To investigate the general impact of the IRF-3 response onto HCV replication in cell culture, we generated an ample array of stable Huh-7 cell lines with altered IRF-3 responsiveness. Neither blocking IRF-3 activation in various host cells by expression of dominant negative RIG-I or HCV NS3/4A protease nor reconstitution of RIG-I signaling in Huh7.5, a cell clone known to be defective in this pathway, had any impact on HCV replication. Only by overexpressing constitutively active RIG-I or the signaling adaptor Cardif (also known as interferon-beta promoter stimulator 1, mitochondrial anti-viral signaling protein, or virus-induced signaling adaptor), both leading to a stimulation of the IRF-3 pathway in the absence of inducers, was HCV replication significantly inhibited. We therefore assessed the extent of RIG-I– dependent IRF-3 activation by different species of RNA, including full-length HCV genomes and HCV RNA duplexes, and observed strong induction only in response to double-stranded RNAs. Conclusion: Based on these findings, we propose a refined model of innate immune escape by HCV involving limited initial induction and stringent subsequent control of the IRF-3 response.Keywords
Funding Information
- National Genome Research Network, NGFN
- German Ministry for Research and Education and the “Kompetenznetz Hepatitis (Teilprojekt 13.2)”
This publication has 27 references indexed in Scilit:
- Complex Modulation of Cell Type-Specific Signaling in Response to Type I InterferonsImmunity, 2006
- Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell cultureCurrent Opinion in Microbiology, 2006
- A target on the move: Innate and adaptive immune escape strategies of hepatitis C virusAntiviral Research, 2006
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- Cell Type-Specific Involvement of RIG-I in Antiviral ResponseImmunity, 2005
- Distinct Poly(I-C) and Virus-activated Signaling Pathways Leading to Interferon-β Production in HepatocytesJournal of Biological Chemistry, 2005
- Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-IJournal of Virology, 2005
- Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFProceedings of the National Academy of Sciences, 2005
- Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine ProteaseScience, 2003
- Transcriptional Profiling of Interferon Regulatory Factor 3 Target Genes: Direct Involvement in the Regulation of Interferon-Stimulated GenesJournal of Virology, 2002